(Q30224457)

10 June 2017

title

Unexpected high levels of multidrug-resistant tuberculosis present new challenges for tuberculosis control (English)

1 reference

multidrug-resistant tuberculosis

10 June 2017

main subject

multiple drug resistance

0 references

tuberculosis

0 references

1 reference

Sven Hoffner

1

1 reference

10 June 2017

language of work or name

English

0 references

publication date

30 August 2012

1 reference

10 June 2017

1 reference

10 June 2017

volume

380

1 reference

10 June 2017

issue

9851

1 reference

10 June 2017

page(s)

1367-1369

1 reference

Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.

10 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961069-1

7 January 2021

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961069-1

7 January 2021

Spread of drug-resistant pulmonary tuberculosis in Estonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961069-1

7 January 2021

Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961069-1

7 January 2021

Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961069-1

7 January 2021

Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961069-1

7 January 2021

Totally drug-resistant tuberculosis in India.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961069-1

7 January 2021

Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961069-1

7 January 2021

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961069-1

7 January 2021

Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961069-1

7 January 2021

10.1016/S0140-6736(12)61069-1

Identifiers

DOI

1 reference

10 June 2017

1 reference